A physician with Pulse Cardiology in San Bernardino, California, has been accused of racist behavior after allegedly criticizing a patient for not speaking English, Yahoo Finance reported Nov. 6.

Canada legalized recreational cannabis countrywide Oct. 17, triggering a national response that’s resulted in near-depletion of the country’s legal marijuana supply. But, as Canadians begin to embrace the new policy, local physician Taylor Lougheed, MD, MSc, suggests heart patients might want to consider their cardiovascular health before lighting up.

Cardiologists and researchers alike are calling for the early halt of a national heart stem cell trial after Harvard Medical School and Brigham and Women’s Hospital expressed concern earlier this week that some of the work the study is based on might be falsified.

The Leapfrog Group, a nonprofit organization that grades nearly 2,000 U.S. hospitals, is expanding its safety and quality ratings to outpatient surgery centers. The group plans to survey 250 centers in 2019 and up to 5,600 in 2020.

Harvard Medical School and Brigham and Women’s Hospital are recommending 31 papers authored by a former lab director be retracted from medical journals, STAT reported this week.

In spite of recent research suggesting statins might carry some benefit for non-CVD patients, a review published in the Annals of Internal Medicine this week concluded they have no role outside of heart disease and could, in some cases, even increase patients’ risk for diabetes and myopathy.

A group of young cardiologists in New York City is opening hybrid health clinics, which combine the in-person guidance of physicians with the latest in digital health technology and screening tools.

A machine learning tool developed by researchers at Michigan State University can accurately predict an individual’s height within an inch and may offer more precise CVD and cancer risk assessment in the future, according to a report featured this month in Genetics.